Post-Pfizer Vaccination Myocarditis in Adolescents: Case Series and Clinical Implications
Seven cases of symptomatic acute myocarditis are reported in adolescents following Pfizer-BioNTech COVID-19 vaccination, raising awareness about potential vaccine-related adverse events and informing ongoing surveillance and monitoring efforts.
January 2022
Aspergillus Tracheobronchitis in COVID-19: Insights into Host-Pathogen Interactions
The interplay between viral tropism, host defense, and fungal invasion contributes to Aspergillus tracheobronchitis in COVID-19 patients, highlighting the complex pathophysiology and clinical implications of opportunistic fungal infections in severe respiratory illness.
January 2022
Future Trajectories of COVID-19: Modeling Possible Scenarios and Public Health Implications
University of Utah scientists model possible futures of COVID-19, exploring different trajectories and their implications for public health preparedness, policy-making, and disease control strategies.
January 2022
Monoclonal Antibodies Reduce Deaths in COVID-19: Insights from the RECOVERY Trial
RECOVERY Trial findings demonstrate that Regeneron's monoclonal antibody combination reduces deaths of hospitalized COVID-19 patients who have not mounted their own immune response, supporting the efficacy of monoclonal antibody therapies in improving clinical outcomes in severe COVID-19 cases.
January 2022
Impact of COVID-19 on Pregnancy and Birth Trends: Insights from Epidemiological Studies
Although the pandemic initially slowed conception rates, a potential baby boom may occur in the near future, underscoring the complex interplay between social, economic, and healthcare factors on fertility trends during crisis situations.
January 2022
